Palantir CEO says fentanyl response would be different 'if 60,000 Yale grads' were dying instead
Palantir CEO Alex Karp said he supports the Trump administration's anti-drug campaign during the company's earnings call and criticized opposition to fentanyl interdiction efforts.
